Botulinum toxin treatment of pelvic floor disorders and genital pain in women
Bertolasi L. Frasson E. Graziottin A. Botulinum toxin treatment of pelvic floor disorders and genital pain in women Current Women’s Health Reviews, 2008, 4, 185-192
Botulinum neurotoxin (BoNT) - already used since the 1980s for strabismus, dystonia and spasticity - has over the past 10 years enjoyed increasing use also for pelvic floor disorders and genital pain. Notwithstanding the relatively few publications available to date the current medical literature suggests that BoNT-A effectively improves chronic pain syndromes, vaginismus, and vulvodynia/VVS. The encouraging preliminary results suggest that BoNT-A is an efficient tool for treating pelvic floor disorders as the only therapy or in a multidisciplinary treatment approach. BoNT-A therapy merits more widespread use in women with pelvic floor disorders and genital pain because it improves symptoms, enhances quality of life and probably reduces social costs BoNT-A.
FAIR USE: The content of this paper can be downloaded, printed and read for strictly personal and non-profit use. Any citation for didactic and/or scientific purpose must quote the title of the document, the name of the author(s), the data of the book or journal, and the URL of the site (www.fondazionegraziottin.org).
WARNING: Every therapy must be discussed, tailored, prescribed and monitored by the M.D. personally consulted. Every information presented in this website can not surrogate the personal relationship with the caring physician nor be utilized without specific medical advice.